Enuresis Clinical Trial
Official title:
How Valuable is Uroflowmetry in Children With Enuresis Nocturnal?
Verified date | December 2021 |
Source | Hisar Intercontinental Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Background: Enuresis nocturna is an important social and psychological problem in children. Uroflowmetry is an important test used to investigate lower urinary tract symptoms.. Objective:To evaluate the uroflowmetry (UFM) results of children with nocturnal enuresis (NE). Method: The uroflowmetry findings of healthy and visualized children without any urinary symptoms and who were prospectively admitted to the urology and pediatric surgery outpatient clinic with the complaint of Enuresis nocturna between January 2020 and July 2021 were compared. Information (anamnesis, physical examination, radiology results and laboratory tests) and uroflowmetry results of NE and healthy children included in the study were recorded.
Status | Completed |
Enrollment | 180 |
Est. completion date | December 11, 2021 |
Est. primary completion date | July 30, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Years to 16 Years |
Eligibility | Inclusion Criteria: Primer monosymptomatic enuresis nocturna Exclusion Criteria: Urinary infectious Diabetes Spina bifida, Epispadias, Hipospadias VUR Extrophia Vesica Epilepsy Cerebral Palsy |
Country | Name | City | State |
---|---|---|---|
Turkey | Hisar Intercontinental Hospital | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Hisar Intercontinental Hospital |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | uroflowmetry | ml/s | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02600676 -
Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis
|
N/A | |
Completed |
NCT02369445 -
Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention
|
N/A | |
Completed |
NCT01978210 -
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
|
N/A | |
Recruiting |
NCT06070675 -
Comparison of a Paper and Automated Bladder Diary in Pediatric Patients
|
N/A | |
Completed |
NCT01747343 -
Toilet Training Toddlers and Preschoolers
|
N/A | |
Recruiting |
NCT00437528 -
Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity
|
Phase 1 | |
Recruiting |
NCT02699528 -
The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Withdrawn |
NCT01861145 -
Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea
|
Phase 4 | |
Completed |
NCT04260646 -
Alarm Treatment for Combined Enuresis and Daytime Urinary Incontinence in Children
|
N/A | |
Completed |
NCT00270621 -
Family Help Program: Nighttime Enuresis Treatment Program
|
Phase 2 | |
Completed |
NCT01367080 -
A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg
|
Phase 1 | |
Completed |
NCT00226122 -
The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal
|
Phase 4 | |
Withdrawn |
NCT03478813 -
Voiding School as a Treatment of Children's Day-time Incontinence or Enuresis
|
N/A | |
Recruiting |
NCT03399877 -
A Study on Accuracy Improvement of Repeated Measure Uroflowmetry- Electromyography
|
N/A | |
Completed |
NCT01036841 -
Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation
|
Phase 4 | |
Active, not recruiting |
NCT06185361 -
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
|
N/A | |
Completed |
NCT04280887 -
MyPad - Intelligent Bladder Pre-void Alerting System
|
N/A | |
Completed |
NCT00240812 -
A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime Bedwetting
|
Phase 2 |